Abstract
192TiP - S-1 and CPT-11 plus ramucirumab (IRIS+Rmab) as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: A multicenter phase II study in Japan (N-DOCC-F-C-1701)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have